LGALS1 and hepatocellular carcinoma: By contrast, Galectin-1 underexpression inhibits the expression of the sorafenib-mediated ferroptosis markers GPX4 and FTH1 and increases lipid peroxidation, restoring the sensitivity to sorafenib of sorafenib-resistant HCC cells.